A Study of Rizatriptan Co-Administered With Acetaminophen for the Treatment of Acute Migraine
Public ClinicalTrials.gov record NCT00300924. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Double-Dummy, Randomized, Parallel-Group, Placebo Controlled Study to Evaluate the Efficacy and Tolerability of Rizatriptan 10mg Co-Administered With Acetaminophen for the Treatment of Acute Migraine.
Study identification
- NCT ID
- NCT00300924
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Diamond Headache Clinic
- Other
- Enrollment
- 200 participants
Conditions and interventions
Conditions
Interventions
- Rizatriptan co-administered with Acetaminophen Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2006
- Primary completion
- Dec 31, 2006
- Completion
- Dec 31, 2006
- Last update posted
- May 27, 2008
2006 – 2007
United States locations
- U.S. sites
- 7
- U.S. states
- 6
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SanFrancisco Headache Clinic | San Francisco | California | 94109 | — |
| Diamond Headache Clinic | Chicago | Illinois | 60614 | — |
| Westside Family Medical Center | Kalamazoo | Michigan | 49009 | — |
| Clinvest | Springfield | Missouri | — | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Elkind Headache Center | Mount Vernon | New York | 10550 | — |
| ClinExcel | West Chester | Ohio | 44121 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00300924, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2008 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00300924 live on ClinicalTrials.gov.